Skip to main content

Advertisement

SpringerLink
Log in

Olfactory Neuroblastoma

  • Head and Neck Cancers (EY Hanna, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To provide a comprehensive review of the literature focusing on the recent advances in the diagnosis and management of olfactory neuroblastoma.

Recent Findings

Multimodality treatment is usually recommended for the majority of ONB cases. Recent advances in surgical approaches include the evolving role of endonasal endoscopic surgical resection and reconstruction. The introduction of new conformal radiation techniques has improved the outcomes and reduced treatment-related toxicity to important structures such as the eye and the brain. The role of neoadjuvant and adjuvant chemotherapy is yet to be defined.

Summary

In the last two decades, there have been advances in surgical techniques with endoscopic approaches, either alone or in combination with craniotomy, gradually replacing the open traditional approaches. Prolonged surveillance is recommended for ONB due to late recurrences associated with that tumor. The role of chemotherapy and elective neck irradiation is still controversial and needs more studies to investigate their optimal role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014;18(S 02):S149–S56. https://doi.org/10.1055/s-0034-1390014.

    Article  PubMed  PubMed Central  Google Scholar 

  2. • Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1):51–9. https://doi.org/10.1007/s12105-014-0547-3. This article represents a large retroscpective cohort study that evaluates the association of Hyams grading and Kadish staging systems with the prognostic outcomes of olfactory neuroblastoma.

    Article  PubMed  Google Scholar 

  3. Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009;16(5):322–31. https://doi.org/10.1097/PAP.0b013e3181b544cf.

    Article  CAS  PubMed  Google Scholar 

  4. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683–90. https://doi.org/10.1016/S1470-2045(01)00558-7.

    Article  CAS  PubMed  Google Scholar 

  5. Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematol Oncol Clin North Am. 2012;26(6):1185–207. https://doi.org/10.1016/j.hoc.2012.08.005.

    Article  PubMed  Google Scholar 

  6. Ow TJ, Hanna EY, Roberts DB, Levine NB, El-Naggar AK, Rosenthal DI, et al. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014;36(4):524–30. https://doi.org/10.1002/hed.23327.

    Article  PubMed  Google Scholar 

  7. Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015;17(1):1–5.

    Article  Google Scholar 

  8. Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 2009;3(3):252–9. https://doi.org/10.1007/s12105-009-0125-2.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ow TJ, Bell D, Kupferman ME, DeMonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013;24(1):51–65. https://doi.org/10.1016/j.nec.2012.08.005.

    Article  PubMed  Google Scholar 

  10. Holland H, Koschny R, Krupp W, Meixensberger J, Bauer M, Kirsten H, et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet. 2007;173(2):89–96. https://doi.org/10.1016/j.cancergencyto.2006.09.024.

    Article  CAS  PubMed  Google Scholar 

  11. Bockmühl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004;14(2):158–63. https://doi.org/10.1111/j.1750-3639.2004.tb00048.x.

    Article  PubMed  Google Scholar 

  12. Guled M, Myllykangas S, Frierson HF, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008;21(6):770–8. https://doi.org/10.1038/modpathol.2008.57.

    Article  CAS  PubMed  Google Scholar 

  13. Lund VJ, Howard D, Wei W, Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope. 2003;113(3):502–7. https://doi.org/10.1097/00005537-200303000-00020.

    Article  PubMed  Google Scholar 

  14. Modesto A, Blanchard P, Tao Y, Rives M, Janot F, Serrano E, et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol. 2013;49(8):830–4. https://doi.org/10.1016/j.oraloncology.2013.04.013.

    Article  CAS  PubMed  Google Scholar 

  15. Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg. 2007;136(1):104–7. https://doi.org/10.1016/j.otohns.2006.04.021.

    Article  PubMed  Google Scholar 

  16. Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesioneuroblastoma: results and outcomes of a single institution's experience. Skull Base. 2009;19(02):133–40. https://doi.org/10.1055/s-0028-1096195.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Josephs L, Jones L, Marenette L, McKeever P. Cushing’s syndrome: an unusual presentation of olfactory neuroblastoma. Skull Base. 2008;18(01):073–6. https://doi.org/10.1055/s-2007-994291.

    Article  Google Scholar 

  18. Koo BK, An JH, Jeon KH, CHOI SH, Cho YM, Jang HC, et al. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J. 2008;55(3):469–75. https://doi.org/10.1507/endocrj.K07E-005.

    Article  PubMed  Google Scholar 

  19. Plasencia YL, Cortés MB, Arencibia DM, Dámaso TM, Contreras IL, Pino AO, et al. Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006;28(12):1142–6. https://doi.org/10.1002/hed.20352.

    Article  PubMed  Google Scholar 

  20. Dublin AB. Imaging characteristics of olfactory neuroblastoma. Skull Base. 2007;17(S 1):A091.

    Google Scholar 

  21. Howell M, Branstetter B, Snyderman C. Patterns of regional spread for esthesioneuroblastoma. Am J Neuroradiol. 2011;32(5):929–33. https://doi.org/10.3174/ajnr.A2401.

    Article  CAS  PubMed  Google Scholar 

  22. Kadish S, Goodman M, Wang C. Olfactory neuroblastoma—a clinical analysis of 17 cases. Cancer. 1976;37(3):1571–6. https://doi.org/10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L.

    Article  CAS  PubMed  Google Scholar 

  23. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32(5):706–15. https://doi.org/10.1227/00006123-199305000-00002.

    Article  CAS  PubMed  Google Scholar 

  24. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970–1990. Laryngoscope. 1992;102(8):843–9. https://doi.org/10.1288/00005537-199208000-00001.

    Article  CAS  PubMed  Google Scholar 

  25. Hyams V, Batsakis J, Michaels L. Tumors of the upper respiratory tract and ear. Armed forces institute of pathology fascicles, 2nd series. Washington: American Registry of Pathology Press; 1988.

    Google Scholar 

  26. Bradley PJ, Jones NS, Robertson I. Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2003;11(2):112–8. https://doi.org/10.1097/00020840-200304000-00009.

    Article  PubMed  Google Scholar 

  27. Gallagher KK, Spector ME, Pepper J-P, McKean EL, Marentette LJ, McHugh JB. Esthesioneuroblastoma updating histologic grading as it relates to prognosis. Ann Otol Rhinol Laryngol. 2014;123(5):353–8. https://doi.org/10.1177/0003489414526368.

    Article  PubMed  Google Scholar 

  28. Kaur G, Kane AJ, Sughrue ME, Madden M, Oh MC, Sun MZ. The prognostic implications of Hyam’s subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci. 2013;20(2):281–6. https://doi.org/10.1016/j.jocn.2012.05.029.

    Article  PubMed  Google Scholar 

  29. Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, et al. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 2010;78(4):992–7. https://doi.org/10.1016/j.ijrobp.2009.09.019.

    Article  PubMed  Google Scholar 

  30. Foote RL, Morita A, Ebersold MJ, Olsen KD, Lewis JE, Quast LM, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993;27(4):835–42. https://doi.org/10.1016/0360-3016(93)90457-7.

    Article  CAS  PubMed  Google Scholar 

  31. Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005;27(2):138–49. https://doi.org/10.1002/hed.20127.

    Article  PubMed  Google Scholar 

  32. Rosenthal DI, Barker JL, El-Naggar AK, Glisson BS, Kies MS, Diaz EM, et al. Sinonasal malignancies with neuroendocrine differentiation. Cancer. 2004;101(11):2567–73. https://doi.org/10.1002/cncr.20693.

    Article  PubMed  Google Scholar 

  33. Gallia GL, Reh DD, Salmasi V, Blitz AM, Koch W, Ishii M. Endonasal endoscopic resection of esthesioneuroblastoma: the Johns Hopkins Hospital experience and review of the literature. Neurosurg Rev. 2011;34(4):465–75. https://doi.org/10.1007/s10143-011-0329-2.

    Article  PubMed  Google Scholar 

  34. Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014;16(2):369. https://doi.org/10.1007/s11912-013-0369-6.

    Article  PubMed  Google Scholar 

  35. Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009;135(12):1219–24. https://doi.org/10.1001/archoto.2009.173.

    Article  PubMed  Google Scholar 

  36. Folbe A, Herzallah I, Duvvuri U, Bublik M, Sargi Z, Snyderman CH, et al. Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy. 2009;23(1):91–4. https://doi.org/10.2500/ajra.2009.23.3269.

    Article  PubMed  Google Scholar 

  37. Nicolai P, Battaglia P, Bignami M, Bolzoni Villaret A, Delù G, Khrais T, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol. 2008;22(3):308–16. https://doi.org/10.2500/ajr.2008.22.3170.

    Article  PubMed  Google Scholar 

  38. Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surgery. 2016;24(1):63–9. https://doi.org/10.1097/MOO.0000000000000220.

    Article  Google Scholar 

  39. Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys. 2007;68(3):758–62. https://doi.org/10.1016/j.ijrobp.2006.12.071.

    Article  PubMed  Google Scholar 

  40. Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg. 2006;132(2):134–8. https://doi.org/10.1001/archotol.132.2.134.

    Article  PubMed  Google Scholar 

  41. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck. 2000;22(6):550–8. https://doi.org/10.1002/1097-0347(200009)22:6<550::AID-HED2>3.0.CO;2-0.

    Article  CAS  PubMed  Google Scholar 

  42. Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation: results in 9 cases. Arch Otolaryngol Head Neck Surg. 1997;123(1):34–40. https://doi.org/10.1001/archotol.1997.01900010038005.

    Article  CAS  PubMed  Google Scholar 

  43. Zanation AM, Ferlito A, Rinaldo A, Gore MR, Lund VJ, McKinney KA, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol. 2010;267(11):1667–71. https://doi.org/10.1007/s00405-010-1360-6.

    Article  PubMed  PubMed Central  Google Scholar 

  44. • Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, et al. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016;6(4):241–7. https://doi.org/10.1016/j.prro.2015.10.023. This article is a retroscpective cohort study that evaluates the effect of elecive neck irradiation on neck relapse risk in olfactory neuroblastoma patients.

    Article  PubMed  Google Scholar 

  45. Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck. 2003;25(7):529–34. https://doi.org/10.1002/hed.10247.

    Article  PubMed  Google Scholar 

  46. Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck treatment? Int J Radiat Oncol Biol Phys. 2011;81(4):e255–e61. https://doi.org/10.1016/j.ijrobp.2011.03.036.

    Article  PubMed  Google Scholar 

  47. Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G, et al. Esthesioneuroblastoma: the Princess Margaret Hospital experience. Head Neck. 2008;30(12):1607–14. https://doi.org/10.1002/hed.20920.

    Article  PubMed  Google Scholar 

  48. • Rimmer J, Lund VJ, Beale T, Wei WI, Howard D. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope. 2014;124(7):1542–9. https://doi.org/10.1002/lary.24562. This article represents a large cohort study reporting the long-term outcomes and recurrence rates in olfactory neuroblastoma patients.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Pickens academic tower, unit 1445, Houston, TX, 77030, USA

    Ahmed S. Abdelmeguid

  2. Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Ahmed S. Abdelmeguid

Authors
  1. Ahmed S. Abdelmeguid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed S. Abdelmeguid.

Ethics declarations

Conflict of Interest

Ahmed S. Abdelmeguid declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Head and Neck Cancers

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelmeguid, A.S. Olfactory Neuroblastoma. Curr Oncol Rep 20, 7 (2018). https://doi.org/10.1007/s11912-018-0661-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11912-018-0661-6

Keywords

Search

Navigation